Choongwae Pharma Coorporation
- South Korea
- Service category
- Partnering/collaboration for drug dossiers, patents, drug candidates, medical technology
Your company? Get access to this profile.
- Cardiovascular Disease
- Licensing / partnering / dealmaking
- Psychiatric / neurodegenerative disorders
Based on leading competitiveness in the prescription drug market, Choongwae has built up strong sales network across the country and superior pipelines in I.V- solutions, antibiotic, cardiovascular, gastrointestinal, nephrology/antianaemic, anticancer and neuropsychiatry. And now, it is pioneering the rapidly growing new field such as diabetes and so on.
Moreover, Choongwae is making efforts to provide medical equipments, various self modification products and OTC products satisfying the requirements for prevention and diagnosis of diseases.
Also, Choongwae has diligently opened up itself to the overseas market with competitive APIs (Active Pharmaceutical Ingredients) and finished products developed on a basis of our creative technologies. Especially, the anti-fungal agents such as Ketoconazole and Itraconazole are lively being exported to developed countries such as EU, Japan with their acquisition of EU CoS.
With an open mind even the competitors in the past can become partners today,
Choongwae has been making steady progress having the confidence that it can build up a win-win partnership at anytime, with anyone and anywhere.
Possible In-Licensing Area:
- Target Identification / Validation
- Drug Delivery System (DDS) Technologies
- Library Construction
Possible Out-Licensing Area:
- Target Program
- (Transcription factor: TCF4, NF-kB, AP-1, HIF-1 etc.)
- beta-turn Library (secondary protein mimic structures)
- Facilities (spray-dryer, solid dispersion etc.)
- Intermediates (BAED/BHMD : statin intermediates)
You might be also interested in
Sourcing this company's services?Send inquiry anonymously »